Abstract
Abstract ED06-03 Biospecimens are required to support translational research leading to the development of biomarkers and clinical assays. Translational research encompasses projects from biomarker discovery through clinical assay development to ultimate validation of biomarkers and assays for clinical use. Each stage along this translational pathway requires appropriate biospecimens with different levels of annotation. The characteristics of biospecimens needed at each level of biomarker/clinical assay development will be discussed. The Cancer Diagnosis Program and other NCI programs support tissue resources that meet some of the need for biospecimens for translational cancer research. The types of resources available and the challenges of maintaining comprehensive biospecimen resources will be discussed. Citation Information: Cancer Prev Res 2008;1(7 Suppl):ED06-03.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
